{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:20:51Z","timestamp":1794003651419,"version":"4.8.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Identifying individuals at-risk for dementia is one of the critical objectives of current research efforts, highlighting the need for simple, cost-effective, and minimally invasive biomarkers. Mild behavioral impairment (MBI), characterized by the emergence of persistent neuropsychiatric manifestations in older adults, has attracted increasing attention as a potential early indicator of cognitive decline and dementia. A growing number of studies have recently begun to explore the relationship between MBI and several blood-based biomarkers associated with Alzheimer\u2019s disease (AD) pathology, neurodegeneration, as well as systemic metabolic and inflammatory dysregulation. In this context, MBI has been associated with lower plasma A\u03b242\/\u0391\u03b240 ratio, higher plasma phosphorylated tau at threonine 181 (p-tau181), increased neurofilament light chain (NfL) levels, as well as disturbances in metabolic markers, including homocysteine, insulin and ferritin, suggesting a multifaceted neurobiological basis for this syndrome. These findings offer insights into the underlying pathophysiology of MBI, and connection between neuropsychiatric symptoms and progression of AD. In this narrative review, we aim to summarize and critically discuss the emerging literature evidence linking MBI to blood-based biomarkers, hoping to shed more light on MBI\u2019s pathophysiology, its connection to AD-related neurobiology, as well as its potential practical utility for predicting cognitive impairment, guiding early interventions and managing the risk for dementia.<\/jats:p>","DOI":"10.3389\/fneur.2025.1534193","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:21:47Z","timestamp":1738819307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Blood-based biomarkers in mild behavioral impairment: an updated overview"],"prefix":"10.3389","volume":"16","author":[{"given":"Efthalia","family":"Angelopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Androni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Hatzimanolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Scarmeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokratis","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1980-5764-dn-2022-s101en","article-title":"Subjective cognitive decline, mild cognitive impairment, and dementia - syndromic approach: recommendations of the scientific Department of Cognitive Neurology and Aging of the Brazilian academy of neurology","volume":"16","author":"Smid","year":"2022","journal-title":"Dementia Neuropsychol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of Dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jalz.2015.12.003","article-title":"Why has therapy development for dementia failed in the last two decades?","volume":"12","author":"Gauthier","year":"2016","journal-title":"Alzheimers Dement"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer's disease: Moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","article-title":"Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer's disease","volume":"11","author":"Chen","year":"2021","journal-title":"Transl Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e14408","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jagp.2013.01.006","article-title":"The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease","volume":"21","author":"Rosenberg","year":"2013","journal-title":"Am J Geriatric Psychiatr Off Psychiatry."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"JAD"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/08919887221093353","article-title":"Validating the mild behavioral impairment checklist in a cognitive clinic: comparisons with the neuropsychiatric inventory questionnaire","volume":"36","author":"Hu","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/cells13131164","article-title":"Unraveling the potential underlying mechanisms of mild behavioral impairment: focusing on amyloid and tau pathology","volume":"13","author":"Angelopoulou","year":"2024","journal-title":"Cells"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/ijms25052645","article-title":"Exploring the genetic landscape of mild behavioral impairment as an early marker of cognitive decline: An Updated review focusing on Alzheimer's Disease","volume":"25","author":"Angelopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/08919887211016068","article-title":"Plasma beta-amyloid in mild behavioural impairment - neuropsychiatric symptoms on the Alzheimer's continuum","volume":"35","author":"Miao","year":"2022","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1212\/WNL.0000000000201517","article-title":"Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal Alzheimer disease","volume":"100","author":"Ghahremani","year":"2023","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1002\/alz.13902","article-title":"Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults","volume":"20","author":"Gonzalez-Bautista","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-200011","article-title":"Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment","volume":"76","author":"Naude","year":"2020","journal-title":"JAD"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1099333","DOI":"10.3389\/fpsyt.2023.1099333","article-title":"A review of current evidence for mild behavioral impairment as an early potential novel marker of Alzheimer's disease","volume":"14","author":"Jin","year":"2023","journal-title":"Front Psych"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-\u03b2 and tau proteins in Alzheimer's disease: confuting the amyloid Cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"JAD"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/ADR-190143","article-title":"Role of fluid biomarkers and PET imaging in early diagnosis and its clinical implication in the Management of Alzheimer's disease","volume":"4","author":"Hameed","year":"2020","journal-title":"J Alzheimer's Dis Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma A\u03b242\/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"P\u00e9rez-Grijalba","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.neurobiolaging.2011.09.004","article-title":"Blood-based biomarkers for Alzheimer's disease: plasma Abeta40 and Abeta42, and genetic variants","volume":"32","author":"Mayeux","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma beta-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF amyloid beta (Abeta) 42\/40 ratio in the diagnosis of Alzheimer's disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/alz.12007","article-title":"Mild behavioral impairment is associated with beta-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","volume":"16","author":"Lussier","year":"2020","journal-title":"Alzheimers Dement"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jagp.2020.01.012","article-title":"The association between biomarkers and neuropsychiatric symptoms across the Alzheimer's disease Spectrum","volume":"28","author":"Banning","year":"2020","journal-title":"Am J Geriatric Psychiatry Off"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1017\/S0033291712001870","article-title":"Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment","volume":"43","author":"Ramakers","year":"2013","journal-title":"Psychol Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13195-020-00701-7","article-title":"Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study","volume":"12","author":"Sannemann","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/JGP.0b013e3181df48be","article-title":"Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease","volume":"18","author":"Blasko","year":"2010","journal-title":"Am J Geriatric Psychiatry Off J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e198964","DOI":"10.1001\/jamanetworkopen.2019.8964","article-title":"Longitudinal association of depression symptoms with cognition and cortical amyloid among community-dwelling older adults","volume":"2","author":"Gatchel","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","article-title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's disease neuroimaging initiative","volume":"26","author":"Karikari","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma Total tau level as a predictive biomarker for dementia and related Endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jalz.2014.07.001","article-title":"Plasma amyloid-beta and risk of Alzheimer's disease in the Framingham heart study","volume":"11","author":"Chouraki","year":"2015","journal-title":"Alzheimers Dement"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma Neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41582-021-00597-3","article-title":"Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities","volume":"18","author":"Ismail","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000137671","article-title":"Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"25","author":"Skogseth","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","article-title":"Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease","volume":"11","author":"Johansson","year":"2021","journal-title":"Transl Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","article-title":"Mood changes in cognitively Normal older adults are linked to Alzheimer disease biomarker levels","volume":"24","author":"Babulal","year":"2016","journal-title":"Am J Geriatric Psychiatr"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41398-021-01675-2","article-title":"Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology","volume":"11","author":"Sun","year":"2021","journal-title":"Transl Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.jns.2020.117229","article-title":"The relationship between neurofilament light chain and cognition in neurological disorders: a scoping review","volume":"420","author":"Ramani","year":"2021","journal-title":"J Neurol Sci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/brainsci14030272","article-title":"Neurofilaments light chain in neurodegenerative dementias: a review of imaging correlates","volume":"14","author":"Gallingani","year":"2024","journal-title":"Brain Sci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer's disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J Neurol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13195-024-01526-4","article-title":"Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression","volume":"16","author":"Rabl","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/ijms21041421","article-title":"Homocysteine: its possible emerging role in at-risk population groups","volume":"21","author":"Azzini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/aje\/kwj347","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a huge review","volume":"165","author":"Gilbody","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders-focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-171042","article-title":"Homocysteine and dementia: an international consensus statement","volume":"62","author":"Smith","year":"2018","journal-title":"JAD."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ana.20645","article-title":"Plasma total homocysteine and memory in the elderly: the Hordaland homocysteine study","volume":"58","author":"Nurk","year":"2005","journal-title":"Ann Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1046\/j.1532-5415.2002.50614.x","article-title":"Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people","volume":"50","author":"Budge","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JAD-220410","article-title":"Serum homocysteine, vitamin B12, folate, and their association with mild cognitive impairment and subtypes of dementia","volume":"90","author":"Song","year":"2022","journal-title":"JAD"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"105763","DOI":"10.1016\/j.neuint.2024.105763","article-title":"High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia","volume":"177","author":"Zuliani","year":"2024","journal-title":"Neurochem Int"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/schbul\/sbt001","article-title":"Pro\u2212\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","volume":"40","author":"Garc\u00eda-Bueno","year":"2014","journal-title":"Schizophr Bull"},{"key":"ref67","first-page":"513","article-title":"Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia","volume":"56","author":"Eren","year":"2010","journal-title":"Clin Lab"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.psychres.2010.04.008","article-title":"Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics","volume":"179","author":"Bouaziz","year":"2010","journal-title":"Psychiatry Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11011-014-9534-3","article-title":"Elevated homocysteine level in first-episode schizophrenia patients\u2014the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab Brain Dis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10072-011-0645-x","article-title":"Cognitive and neurochemical alterations in hyperhomocysteinemic rat","volume":"33","author":"Gao","year":"2012","journal-title":"Neurol Sci Off J Italian Neurol Soc Neurophysiol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2005.07.003","article-title":"Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity","volume":"197","author":"Algaidi","year":"2006","journal-title":"Exp Neurol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3233\/JAD-2010-1284","article-title":"B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A","volume":"19","author":"Nicolia","year":"2010","journal-title":"JAD"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3233\/JAD-230898","article-title":"Mild behavioral impairment and cerebrovascular profiles are associated with early cognitive impairment in a community-based southeast Asian cohort","volume":"97","author":"Leow","year":"2024","journal-title":"JAD"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/JGP.0b013e31823038db","article-title":"Psychiatric disorders presenting in the elderly with type 2 diabetes mellitus","volume":"20","author":"Alagiakrishnan","year":"2012","journal-title":"Am J Geriatric Psychiatr"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"lancet Diab Endocrinol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimers Dement"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/dc08-1341","article-title":"Depression and diabetes treatment nonadherence: a meta-analysis","volume":"31","author":"Gonzalez","year":"2008","journal-title":"Diabetes Care"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/NDT.S240529","article-title":"The effect of type 2 diabetes mellitus on neuropsychological symptoms in Chinese early Alzheimer's disease population","volume":"16","author":"Shi","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neurobiolaging.2005.09.004","article-title":"Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis","volume":"26","author":"Rasgon","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref82","first-page":"207","article-title":"Ferritin: an iron storage protein with diverse functions","volume":"1","author":"Joshi","year":"1988","journal-title":"Biofactors"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"117419","DOI":"10.1016\/j.biopha.2024.117419","article-title":"The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: pathophysiological insights and therapeutic prospects","volume":"179","author":"Tian","year":"2024","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-2010-1239","article-title":"Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment","volume":"19","author":"Smith","year":"2010","journal-title":"JAD"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"830569","DOI":"10.3389\/fnagi.2022.830569","article-title":"Iron Dyshomeostasis and Ferroptosis: a new Alzheimer's disease hypothesis?","volume":"14","author":"Wang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jnr.490310111","article-title":"A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains","volume":"31","author":"Connor","year":"1992","journal-title":"J Neurosci Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fnagi.2013.00088","article-title":"High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease","volume":"5","author":"Bester","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PSY.0b013e3182414f7d","article-title":"Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population","volume":"74","author":"Stewart","year":"2012","journal-title":"Psychosom Med"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnhum.2017.00442","article-title":"Quantitative susceptibility mapping reveals an association between brain Iron load and depression severity","volume":"11","author":"Yao","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3946320231209839","DOI":"10.1177\/03946320231209839","article-title":"Novel anti-amyloid-beta (Abeta) monoclonal antibody lecanemab for Alzheimer's disease: a systematic review","volume":"37","author":"Chowdhury","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12877-021-02253-3","article-title":"The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Geriatr"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","article-title":"Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review","volume":"265","author":"Avgerinos","year":"2018","journal-title":"J Neurol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1567205020666230522102641","article-title":"Associations between the use of metformin and behavioral and psychological symptoms in patients with Alzheimer s disease, and type 2 diabetes mellitus - a register-based study","volume":"20","author":"Kullenberg","year":"2023","journal-title":"Curr Alzheimer Res"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased plasma Beta-secretase 1 may predict conversion to Alzheimer's disease dementia in individuals with mild cognitive impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol Psychiatry"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat Med"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain J Neurol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/life13101954","article-title":"Interaction of proteins involved in neuronal Proteinopathies","volume":"13","author":"Kulichikhin","year":"2023","journal-title":"Life"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/ijms252211941","article-title":"Neuroinflammatory biomarkers in Alzheimer's disease: from pathophysiology to clinical implications","volume":"25","author":"Roveta","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"e210225","DOI":"10.1212\/WNL.0000000000210225","article-title":"Blood-based biomarkers and risk of onset of mild cognitive impairment over the short and long term","volume":"104","author":"Soldan","year":"2025","journal-title":"Neurology"},{"key":"ref101","author":"Villa","year":"2025"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1534193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:21:52Z","timestamp":1738819312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1534193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":101,"alternative-id":["10.3389\/fneur.2025.1534193"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1534193","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"article-number":"1534193"}}